
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
The San Jose-based botanical extract supplier recently passed a Good Manufacturing Practices (GMP) inspection conducted by SGS.
“As a supplier of botanical ingredients, it is not a direct requirement for us to have cGMPs in our processing facility, but it is a requirement for many of our customers.”
In addition to Draco’s successful GMP inspection, the company offers other certifications, including National Organic Program (NOP) and EU organic certification and kosher certification.






